Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 1:20 AM
NCT ID:
NCT06050993
Eligibility Criteria:
Inclusion Criteria:
* Adult patients who are beneficiaries of a social security scheme or beneficiaries entitled to it
* Patients followed for a cirrhotic pathology at the Paul Brousse hospital and benefiting from a scheduled anaesthesia consultation for a scheduled interventional or surgical procedure
* For non-cirrhotic patients: adult patients who are beneficiaries of a social security scheme or beneficiaries entitled to it, benefiting from a blood test scheduled as part of their usual preoperative care (patients in the hepatology or digestive surgery department operated on at the Paul Brousse hospital)
Exclusion Criteria:
* Patient not wishing to participate in the study
* Patient with a known haemostasis abnormality other than cirrhosis
* Patient on long-term antiplatelet or anticoagulant therapy
* Patient who has taken a non-steroidal anti-inflammatory drug within 5 days prior to the blood test
* Patients with thrombopathy of genetic origin
* Patient on estrogenic therapy
* Patient with cancer under treatment or treated in the last 6 months
* Patient on immunosuppressive or immunomodulatory therapy
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06050993
Study Brief:
Protocol Section:
NCT06050993